InvestmentApr 30, 2026, 04:28 PM
GHRS Completes $117.5M Underwritten Offering of 6.53M Shares
AI Summary
GH Research PLC announced the completion of an underwritten offering, selling 6,527,779 ordinary shares at $18.00 per share. This offering generated approximately $117.5 million in gross proceeds, with estimated net proceeds of $111.2 million. The company intends to use these funds to strategically invest in research, clinical and technical development of current and additional product candidates, pre-commercialization activities, working capital, capital expenditures, and general corporate purposes.
Key Highlights
- GH Research PLC completed an underwritten offering of 6,527,779 ordinary shares.
- The offering price for the shares was $18.00 per share.
- Total gross proceeds from the offering were approximately $117.5 million.
- Estimated net proceeds are approximately $111.2 million after expenses.
- Proceeds will fund research, clinical and technical development of product candidates.
- Funds will also be used for pre-commercialization activities, working capital, and general corporate purposes.
- Stifel, Cantor Fitzgerald, and RBC Capital Markets acted as joint book-running managers.
Price Impact
More from GHRS